ALKS vs NOC · P/E 14, rev $1.56B vs P/E 17, rev $41.95B
Alkermes Plc (ALKS) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the ALKS and NOC stock pages for the full models.
Not investment advice.